From: Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
N
Overall survival
Disease-free survival
1-year
2-year
3-year
LPN status
Positive LPN
15
85.7%
67.5%
46.3%
42.9%
34.3%
Negative LPN
58
94.3%
86.7%
83.7%
79.9%
75.9%
67.3%